FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ronald Herberman

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Disorders

Neoplasms

Procedures

Co-author Network

Publications

TOP 3
Vera Levina; Adele M Marrangoni; Tingting Wang; Simul Parikh; Yunyun Su; Ronald Herberman; Anna Lokshin; Elieser Gorelik
Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.
Keith H Morgenlander; Sharon B Winters; Chyongchiou J Lin; Linda B Robertson; Dwight E Heron; Ronald Herberman
Novel method for benchmarking recruitment of African American cancer patients to clinical therapeutic trials.
Devra Lee Davis; Maryann Donovan; Ronald Herberman; Mitchell Gaynor; Deborah Axelrod; Nicolas van Larebeke; Annie J Sasco
The need to develop centers for environmental oncology.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ronald Herberman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Vera Levina; Adele M Marrangoni; Tingting Wang; Simul Parikh; Yunyun Su; Ronald Herberman; Anna Lokshin; Elieser Gorelik
Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.
Cancer research 2010;70(1):338-46.
2008: Keith H Morgenlander; Sharon B Winters; Chyongchiou J Lin; Linda B Robertson; Dwight E Heron; Ronald Herberman
Novel method for benchmarking recruitment of African American cancer patients to clinical therapeutic trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5074-7.
2007: Devra Lee Davis; Maryann Donovan; Ronald Herberman; Mitchell Gaynor; Deborah Axelrod; Nicolas van Larebeke; Annie J Sasco
The need to develop centers for environmental oncology.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2007;61(10):614-22.
2007: Shuang Wei; Ilona Kryczek; Robert P Edwards; Linhua Zou; Wojciech Szeliga; Mousumi Banerjee; Marilyn Cost; Pui Cheng; Alfred E Chang; Bruce G Redman; Ronald Herberman; Weiping Zou
Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.
Cancer research 2007;67(15):7487-94.
2006: Ronald Herberman; Homer L Pearce; Scott M Lippman; Bruce Pyenson; David S Alberts
Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
Cancer research 2006;66(24):11540-9.
2006: Michael Boyiadzis; Kenneth A Foon; Ronald Herberman
NK cells in cancer immunotherapy: three decades of discovery.
Discovery medicine 2006;6(36):243-8.
2006: Bratislav Janjic; Pedro Andrade; Xiao-Fei Wang; Julien Fourcade; Christine Almunia; Pavol Kudela; Adam Brufsky; Samuel Jacobs; David M Friedland; Ronald G Stoller; Daniel Gillet; Ronald Herberman; John M Kirkwood; Bernard Maillere; Hassane M Zarour
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2717-27.
2005: Robbie B Mailliard; Sean Alber; Hongmei Shen; simon simon watkins; John M Kirkwood; Ronald Herberman; Pawel Kalinski
IL-18-induced CD83+CCR7+ NK helper cells.
The Journal of experimental medicine 2005;202(7):941-53.
2005: Pawel Kalinski; Robbie B Mailliard; Adam Giermasz; Herbert J Zeh; Per H Basse; David L Bartlett; John M Kirkwood; Michael T Lotze; Ronald Herberman
Natural killer-dendritic cell cross-talk in cancer immunotherapy.
Expert opinion on biological therapy 2005;5(10):1303-15.
2005: Elieser Gorelik; Douglas Landsittel; Adele M Marrangoni; Francesmary Modugno; Lyudmila Velikokhatnaya; Matthew T Winans; William L Bigbee; Ronald Herberman; Anna Lokshin
Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):981-7.
2005: Ronald Glaser; David A Padgett; Monica L Litsky; Robert A Baiocchi; Eric V Yang; Min Chen; Peir-En Yeh; Nancy Klimas; Gailen D Marshall; Theresa Whiteside; Ronald Herberman; Janice K Kiecolt-Glaser; Marshall V Williams
Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer.
Brain, behavior, and immunity 2005;19(2):91-103.
2004: Shen Li; Jun Xu; Valeria P Makarenkova; Tjendimin Tjandrawan; Jukka Vakkila; Torsten E Reichert; William Gooding; Carl F Lagenaur; Cristian L Achim; William Chambers; Ronald Herberman; Theresa L Whiteside; Nikola L Vujanovic
A novel epitope of N-CAM defines precursors of human adherent NK cells.
Journal of leukocyte biology 2004;76(6):1187-99.
2004: Ronald Herberman
Translation of scientific insights to benefit patients with cancer.
Cancer biology & therapy 2004;3(8):778-81.
2004: Timothy R Gerrity; Dimitris A Papanicolaou; Jay D Amsterdam; Stephen F Bingham; Ashley Grossman; Terry Hedrick; Ronald Herberman; Gerhard Krueger; Susan Levine; Nahid Mohagheghpour; Rebecca C Moore; James M Oleske; Christopher R Snell
Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health.
Neuroimmunomodulation 2004;11(6):351-7.
2003: Qin Yang; Marianne Hokland; John L Bryant; Yuquing Zhang; Ulf Nannmark; simon simon watkins; Ronald H Goldfarb; Ronald Herberman; Per H Basse
Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases.
International journal of cancer. Journal international du cancer 2003;105(4):512-9.
2002: Yuji Satoh; Clemens Esche; Andrea Gambotto; Galina V Shurin; Zoya R Yurkovetsky; Paul D Robbins; simon simon watkins; Satoru Todo; Ronald Herberman; Michael T Lotze; Michael R Shurin
Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.
Journal of experimental therapeutics & oncology 2002;2(6):337-49.
2002: Ronald Herberman
Cancer immunotherapy with natural killer cells.
Seminars in oncology 2002;29(3 Suppl 7):27-30.
2002: Per H Basse; Theresa L Whiteside; Ronald Herberman
Cancer immunotherapy with interleukin-2-activated natural killer cells.
Molecular biotechnology 2002;21(2):161-70.
2002: Linda K Ernst; Diana Metes; Ronald Herberman; Penelope A Morel
Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells.
Journal of molecular medicine (Berlin, Germany) 2002;80(4):248-57.
2001: Mengfeng Li; Xiaojun Huang; Zhenyu Zhu; Michael Wong; simon simon watkins; Qun Zhao; Ronald Herberman; Elieser Gorelik
Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(6):472-81.
2001: B J Wahlberg; Dennis Burholt; Paul Kornblith; T J Richards; A Bruffsky; Ronald Herberman; Nikola L Vujanovic
Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Journal of immunological methods 2001;253(1-2):69-81.
2001: Per H Basse; T L Whiteside; W Chambers; Ronald Herberman
Therapeutic activity of NK cells against tumors.
International reviews of immunology 2001;20(3-4):439-501.
2001: A Sulica; Penelope A Morel; Diana Metes; Ronald Herberman
Ig-binding receptors on human NK cells as effector and regulatory surface molecules.
International reviews of immunology 2001;20(3-4):371-414.
2000: Ronald Herberman
Role of natural killer cells and T cells in immune surveillance.
Leukemia research 2000;24(9):775.
2000: Ronald Herberman; Theresa L Whiteside
Summary of the International Cancer Microenvironment from meeting in Pittsburgh, Pennsylvania on October 3-6, 1999.
Cancer research 2000;60(5):1465-9.
2000: Per H Basse; T L Whiteside; Ronald Herberman
Use of activated natural killer cells for tumor immunotherapy in mouse and human.
Methods in molecular biology (Clifton, N.J.) 2000;121():81-94.
1999: Ofer Shpilberg; J Wilson; Theresa L Whiteside; Ronald Herberman
Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group.
Leukemia & lymphoma 1999;36(1-2):109-21.
1999: Y Kashii; R Giorda; Ronald Herberman; Theresa L Whiteside; Nikola L Vujanovic
Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5358-66.
1999: Diana Metes; M Manciulea; D Pretrusca; Hannah Rabinowich; Linda K Ernst; iulia popescu; Ana Calugaru; A Sulica; William Chambers; Ronald Herberman; Penelope A Morel
Ligand binding specificities and signal transduction pathways of Fc gamma receptor IIc isoforms: the CD32 isoforms expressed by human NK cells.
European journal of immunology 1999;29(9):2842-52.
1999: J Lu; Ken Patrene; PM Appasamy; Ronald Herberman; SS Boggs
Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma.
Experimental hematology 1999;27(6):1046-56.
1999: J Lu; Ken Patrene; Ronald Herberman; SS Boggs
Expression of murine CD34 by fetal liver NK cell progenitors.
Experimental hematology 1999;27(2):272-81.
1998: Paul H Levine; T L Whiteside; D Friberg; J Bryant; G Colclough; Ronald Herberman
Dysfunction of natural killer activity in a family with chronic fatigue syndrome.
Clinical immunology and immunopathology 1998;88(1):96-104.
1998: Lawrence M Pfeffer; C A Dinarello; Ronald Herberman; B R Williams; Ernest C Borden; Ronald Bordens; Mark R Walter; TL Nagabhushan; PP Trotta; Sidney Pestka
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
Cancer research 1998;58(12):2489-99.
1998: Mark R Walter; Ronald Bordens; TL Nagabhushan; B R Williams; Ronald Herberman; C A Dinarello; Ernest C Borden; PP Trotta; Sidney Pestka; Lawrence M Pfeffer
Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
Cancer biotherapy & radiopharmaceuticals 1998;13(3):143-54.
1998: S Nagashima; Robbie B Mailliard; Y Kashii; Torsten E Reichert; Ronald Herberman; P Robbins; Theresa L Whiteside
Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
Blood 1998;91(10):3850-61.
1998: Zvi Grossman; Ronald Herberman; N Vatnik; N Intrator
Conservation of total T-cell counts during HIV infection: alternative hypotheses and implications.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;17(5):450-7.
1998: Diana Metes; Linda K Ernst; William Chambers; A Sulica; Ronald Herberman; Penelope A Morel
Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.
Blood 1998;91(7):2369-80.
1998: Theresa L Whiteside; Nikola L Vujanovic; Ronald Herberman
Natural killer cells and tumor therapy.
Current topics in microbiology and immunology 1998;230():221-44.
1997: Robert P Edwards; William Gooding; Barry C Lembersky; K Colonello; R Hammond; C Paradise; C D Kowal; Alan J Kunschner; Marie Baldisseri; John M Kirkwood; Ronald Herberman
Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: twenty-four-hour versus 7-day infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3399-407.
1997: Ronald Herberman
Effect of alpha-interferons on immune function.
Seminars in oncology 1997;24(3 Suppl 9):S9-78-S9-80.
1997: J M Kirkwood; J Wilson; Theresa L Whiteside; S Donnelly; Ronald Herberman
Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma.
Cancer immunology, immunotherapy : CII 1997;44(3):137-49.
1997: Zvi Grossman; Ronald Herberman
T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host.
Nature medicine 1997;3(5):486-90.
1997: N P Plotnikoff; R E Faith; A J Murgo; Ronald Herberman; R A Good
Methionine enkephalin: a new cytokine--human studies.
Clinical immunology and immunopathology 1997;82(2):93-101.
1996: D R Vlock; J Andersen; L A Kalish; Jonas T Johnson; John M Kirkwood; Theresa L Whiteside; Ronald Herberman; G S Adams; M M Oken; R E Haselow
Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):433-42.
1996: A Sulica; Ronald Herberman
Cytophilic immunoglobulins revisited via natural killer cells.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1996;10(13):1495-504.
1996: Hannah Rabinowich; M Manciulea; Ronald Herberman; Theresa L Whiteside
Beta1 integrin-mediated activation of focal adhesion kinase and its association with Fyn and Zap-70 in human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(9):3860-8.
1996: Hugo O Besedovsky; Ronald Herberman; Lydia R Temoshok; F Sendo
Psychoneuroimmunology and cancer: fifteenth Sapporo Cancer Seminar.
Cancer research 1996;56(18):4278-81.
1996: Hannah Rabinowich; M Manciulea; Diana Metes; A Sulica; Ronald Herberman; Seth J Corey; Theresa L Whiteside
Physical and functional association of Fc mu receptor on human natural killer cells with the zeta- and Fc epsilon RI gamma-chains and with src family protein tyrosine kinases.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(4):1485-91.
1996: Nikola L Vujanovic; S Nagashima; Ronald Herberman; Theresa L Whiteside
Nonsecretory apoptotic killing by human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(3):1117-26.
1996: A Sulica; Diana Metes; M Gherman; Theresa L Whiteside; Ronald Herberman
Divergent effects of Fc gamma RIIIA ligands on the functional activities of human natural killer cells in vitro.
European journal of immunology 1996;26(6):1199-203.
1996: D P Skoner; Theresa L Whiteside; J W Wilson; W J Doyle; Ronald Herberman; P Fireman
Effect of influenza A virus infection on natural and adaptive cellular immunity.
Clinical immunology and immunopathology 1996;79(3):294-302.
1996: K Okada; Ulf Nannmark; N L Vujanovic; S Watkins; Per H Basse; Ronald Herberman; T L Whiteside
Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.
Cancer research 1996;56(7):1599-608.
1996: Domenico Vittorio Delfino; Ken Patrene; J Lu; Albert B DeLeo; R Deleo; Ronald Herberman; SS Boggs
Natural killer cell precursors in the CD44neg/dim T-cell receptor population of mouse bone marrow.
Blood 1996;87(6):2394-400.
1996: M Manciulea; Hannah Rabinowich; A Sulica; W C Lin; Theresa L Whiteside; Albert B DeLeo; Ronald Herberman; Seth J Corey
Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells.
Cellular immunology 1996;167(1):63-71.
1995: T L Whiteside; Ronald Herberman
The role of natural killer cells in immune surveillance of cancer.
Current opinion in immunology 1995;7(5):704-10.
1995: C Galatiuc; M Gherman; Diana Metes; A Sulica; Albert B DeLeo; Theresa L Whiteside; Ronald Herberman
Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
Cellular immunology 1995;163(2):167-77.
1995: Nikola L Vujanovic; Lorenzo Polimeno; A Azzarone; Antonio Francavilla; William Chambers; Thomas E Starzl; Ronald Herberman; Theresa L Whiteside
Changes of liver-resident NK cells during liver regeneration in rats.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(12):6324-38.
1995: Hannah Rabinowich; W C Lin; M Manciulea; Ronald Herberman; Theresa L Whiteside
Induction of protein tyrosine phosphorylation in human natural killer cells by triggering via alpha 4 beta 1 or alpha 5 beta 1 integrins.
Blood 1995;85(7):1858-64.
1995: H Hirabayashi; S Yasumura; W C Lin; Andrew A Amoscato; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Archives of otolaryngology--head & neck surgery 1995;121(3):285-92.
1995: Hannah Rabinowich; W C Lin; Andrew A Amoscato; Ronald Herberman; Theresa L Whiteside
Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(3):1124-35.
1995: William Chambers; Andrew A Amoscato; M Susan Smith; T W Kenniston; Ronald Herberman; PM Appasamy
Prolactin receptor expression by rat NK cells.
Natural immunity 1995;14(3):145-56.
1995: A Sulica; William Chambers; M Manciulea; Diana Metes; Seth J Corey; Hannah Rabinowich; Theresa L Whiteside; Ronald Herberman
Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies.
Natural immunity 1995;14(3):123-33.
1995: Nikola L Vujanovic; S Yasumura; H Hirabayashi; W C Lin; S Watkins; Ronald Herberman; Theresa L Whiteside
Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(1):281-9.
1995: Ronald Herberman
Potential role of natural antibodies in resistance to tumor growth.
Natural immunity 1995;14(1):1.
1994: L Lu; Ronald Herberman; Albert B DeLeo
Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells.
Natural immunity 1994;13(6):315-30.
1994: Hannah Rabinowich; W C Lin; Ronald Herberman; Theresa L Whiteside
Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(8):3504-13.
1994: S Yasumura; W C Lin; H Hirabayashi; Nikola L Vujanovic; Ronald Herberman; Theresa L Whiteside
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.
Cancer research 1994;54(14):3808-16.
1994: Domenico Vittorio Delfino; Ken Patrene; Albert B DeLeo; R DeLeo; Ronald Herberman; SS Boggs
Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(11):5171-9.
1994: M Kim; L Duty; Ronald Herberman; Elieser Gorelik
Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Cellular immunology 1994;155(2):358-71.
1994: S Yasumura; E Weidmann; H Hirabayashi; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
International journal of cancer. Journal international du cancer 1994;57(3):297-305.
1994: K Wasserman; Richard P Kitson; A J Rivett; S T Sweeney; M K Gabauer; Ronald Herberman; simon simon watkins; Ronald H Goldfarb
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex.
Journal of cellular biochemistry 1994;55(1):133-45.
1994: Andrew A Amoscato; R R Spiess; A M Brumfield; Ronald Herberman; William Chambers
Surface aminopeptidase activity of rat natural killer cells. I. Biochemical and biological properties.
Biochimica et biophysica acta 1994;1221(3):221-32.
1994: Ronald H Goldfarb; Theresa L Whiteside; Per H Basse; W C Lin; Nikola L Vujanovic; Ronald Herberman
Natural killer cells and gene therapy: potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases.
Natural immunity 1994;13(2-3):131-40.
1994: Theresa L Whiteside; Ronald Herberman
Role of human natural killer cells in health and disease.
Clinical and diagnostic laboratory immunology 1994;1(2):125-33.
1994: Hannah Rabinowich; L Pricop; Ronald Herberman; Theresa L Whiteside
Expression and function of CD7 molecule on human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(2):517-26.
1994: M Kim; Ronald Herberman; Elieser Gorelik
Evidence for indirect involvement of the H-2Kb gene in the regulation of natural killer sensitivity of BL6 melanoma cells.
Natural immunity 1994;13(1):1-14.
1994: K Wasserman; Richard P Kitson; M K Gabauer; C A Miller; Ronald Herberman; Ronald H Goldfarb
Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells.
In vivo (Athens, Greece) 1994;8(1):33-41.
1994: Per H Basse; Ronald H Goldfarb; Ronald Herberman; Marianne Hokland
Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2.
In vivo (Athens, Greece) 1994;8(1):17-24.
1994: M Begovic; Ronald Herberman; Elieser Gorelik
Up-regulation of tumor cell sensitivity to natural cell-mediated cytotoxicity by UV light irradiation.
Immunology series 1994;61():105-24.
1993: T Aoki; H Miyakoshi; Y Usuda; Ronald Herberman
Low NK syndrome and its relationship to chronic fatigue syndrome.
Clinical immunology and immunopathology 1993;69(3):253-65.
1993: Theresa L Whiteside; E Letessier; H Hirabayashi; D Vitolo; J Bryant; L Barnes; Carl H Snyderman; Jonas T Johnson; E Myers; Ronald Herberman
Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Cancer research 1993;53(23):5654-62.
1993: Hannah Rabinowich; Ronald Herberman; Theresa L Whiteside
Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.
Cellular immunology 1993;152(2):481-98.
1993: Zvi Grossman; Z Bentwich; Ronald Herberman
From HIV infection to AIDS: are the manifestations of effective immune resistance misinterpreted?
Clinical immunology and immunopathology 1993;69(2):123-35.
1993: David P Skoner; T L Whiteside; J W Wilson; William J Doyle; Ronald Herberman; Philip Fireman
Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects.
The Journal of allergy and clinical immunology 1993;92(5):732-43.
1993: Nikola L Vujanovic; Hannah Rabinowich; Y J Lee; L Jost; Ronald Herberman; Theresa L Whiteside
Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
Cellular immunology 1993;151(1):133-57.
1993: M Kim; Ronald Herberman; Elieser Gorelik
Increased sensitivity to TNF-mediated cytotoxicity of BL6 melanoma cells after H-2Kb gene transfection.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(7):3467-77.
1993: L Pricop; Hannah Rabinowich; P A Morel; A Sulica; Theresa L Whiteside; Ronald Herberman
Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(6):3018-29.
1993: Y Shimizu; K Hata; Ronald Herberman; T L Whiteside
51Cr-labeled human hepatocytes as target cells for cytotoxicity mediated by freshly isolated liver-infiltrating lymphocytes.
Journal of immunological methods 1993;164(1):69-77.
1993: D Vitolo; Nikola L Vujanovic; Hannah Rabinowich; M Schlesinger; Ronald Herberman; Theresa L Whiteside
Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(4):1926-37.
1993: M Begovic; Ronald Herberman; Elieser Gorelik
Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis.
Natural immunity 1993;12(4-5):250-66.
1993: Hannah Rabinowich; P Sedlmayr; Ronald Herberman; Theresa L Whiteside
Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(11):4844-55.
1993: Andrew A Amoscato; R R Spiess; S B Sansoni; Ronald Herberman; William Chambers
Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases.
Brain, behavior, and immunity 1993;7(2):176-87.
1993: Xiaoying Yin; Martin L Smith; Theresa L Whiteside; Jonas T Johnson; Ronald Herberman; Joseph Locker
Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 1993;54(2):322-7.
1993: A Sulica; C Galatiuc; M Manciulea; A C Bancu; Albert B DeLeo; Theresa L Whiteside; Ronald Herberman
Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity.
Cellular immunology 1993;147(2):397-410.
1993: S Yasumura; H Hirabayashi; D R Schwartz; J F Toso; J T Johnson; Ronald Herberman; Theresa L Whiteside
Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Cancer research 1993;53(6):1461-8.
1993: F Vecchini; Domenico Vittorio Delfino; Ken Patrene; Albert B DeLeo; L Lu; Ronald Herberman; SS Boggs
Generation of natural killer cells from long-term cultures of mouse bone marrow.
Natural immunity 1993;12(1):1-16.
1993: D Vitolo; Anisa Kanbour; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):371-7.
1992: Ronald Herberman
Tumor immunology.
JAMA : the journal of the American Medical Association 1992;268(20):2935-9.
1992: E Weidmann; M Sacchi; Stephane Plaisance; D S Heo; S Yasumura; W C Lin; Jonas T Johnson; Ronald Herberman; B Azzarone; Theresa L Whiteside
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
Cancer research 1992;52(21):5963-70.
1992: E Weidmann; Theresa L Whiteside; R Giorda; Ronald Herberman; Massimo Trucco
The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Cancer research 1992;52(21):5913-20.
1992: Michael T Lotze; H J Zeh; Elaine Elder; Q Cai; B A Pippin; M M Rosenstein; Theresa L Whiteside; Ronald Herberman
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(3):212-7.
1992: Ronald H Goldfarb; K Wasserman; Ronald Herberman; Richard P Kitson
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(6):2061-8.
1992: Y Shimizu; Anthony J Demetris; Susanne M Gollin; P D Storto; H M Bedford; S Altarac; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
International journal of cancer. Journal international du cancer 1992;52(2):252-60.
1992: Hannah Rabinowich; D Vitolo; S Altarac; Ronald Herberman; Theresa L Whiteside
Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(1):340-9.
1992: Per H Basse; Ronald Herberman; Marianne Hokland; Ronald H Goldfarb
Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.
Natural immunity 1992;11(4):193-202.
1992: D Vitolo; T Zerbe; Anisa Kanbour; C Dahl; Ronald Herberman; Theresa L Whiteside
Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.
International journal of cancer. Journal international du cancer 1992;51(4):573-80.
1992: William Chambers; A M Brumfield; K Hanley-Yanez; R Lakomy; Ronald Herberman; D C McCaslin; M W Olszowy; J P McCoy
Functional heterogeneity between NKR-P1bright/Lycopersicon esculentum lectin (L.E.)bright and NKR-P1bright/L.E.dim subpopulations of rat natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(11):3658-65.
1992: K Hata; David H Van Thiel; Ronald Herberman; Theresa L Whiteside
Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.
Hepatology (Baltimore, Md.) 1992;15(5):816-23.
1992: Zvi Grossman; Ronald Herberman; S Livnat
Neural modulation of immunity: conditioning phenomena and the adaptability of lymphoid cells.
The International journal of neuroscience 1992;64(1-4):275-90.
1992: R R Salup; D C Sicker; N Wolmark; Ronald Herberman; Thomas R Hakala
Chemoimmunotherapy of metastatic murine renal cell carcinoma using flavone acetic acid and interleukin 2.
The Journal of urology 1992;147(4):1120-3.
1992: Ronald Herberman
Adoptive therapy with purified CD8 cells in HIV infection.
Seminars in hematology 1992;29(2 Suppl 1):35-40.
1992: P Sedlmayr; Hannah Rabinowich; A Winkelstein; Ronald Herberman; Theresa L Whiteside
Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
British journal of cancer 1992;65(2):222-8.
1992: J Bryant; R Day; Theresa L Whiteside; Ronald Herberman
Calculation of lytic units for the expression of cell-mediated cytotoxicity.
Journal of immunological methods 1992;146(1):91-103.
1992: Theresa L Whiteside; L M Jost; Ronald Herberman
Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.
Critical reviews in oncology/hematology 1992;12(1):25-47.
1992: Per H Basse; Ronald Herberman; Marianne Hokland; Ronald H Goldfarb
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels.
Cancer immunology, immunotherapy : CII 1992;34(4):221-7.
1992: Theresa L Whiteside; Ronald Herberman
Extravasation of antitumor effector cells.
Invasion & metastasis 1992;12(2):128-46.
1992: S M Levy; L T Haynes; Ronald Herberman; J Lee; S McFeeley; J Kirkwood
Mastectomy versus breast conservation surgery: mental health effects at long-term follow-up.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 1992;11(6):349-54.
1991: M Begovic; Ronald Herberman; Elieser Gorelik
Ultraviolet light-induced increase in tumor cell susceptibility to TNF-dependent and TNF-independent natural cell-mediated cytotoxicity.
Cellular immunology 1991;138(2):349-59.
1991: Theresa L Whiteside; J Wilson; J Bryant; Adriana Zeevi; K Abu el-Magd; Ashok Jain; Mario Alessiani; John Fung; Ronald Herberman; Thomas E Starzl
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.
Transplantation proceedings 1991;23(6):3047-51.
1991: Y Shimizu; E Weidmann; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Cancer research 1991;51(22):6153-62.
1991: Xiaoying Yin; M Donovan-Peluso; Theresa L Whiteside; Jonas T Johnson; R Day; Ronald Herberman; Joseph Locker
Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.
Genes, chromosomes & cancer 1991;3(6):443-54.
1991: Marcel R M van den Brink; Ronald Herberman; J C Hiserodt
Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat.
Blood 1991;78(9):2392-5.
1991: Ronald Herberman; M S Ernstoff; J M Kirkwood
Interferon alpha in combination with other biologics: the scientific rationale.
British journal of haematology 1991;79 Suppl 1():78-80.
1991: M Begovic; Ronald Herberman; Elieser Gorelik
Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
Cancer research 1991;51(19):5153-9.
1991: P Sedlmayr; Hannah Rabinowich; E M Elder; M S Ernstoff; J M Kirkwood; Ronald Herberman; Theresa L Whiteside
Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(5):336-46.
1991: K Hata; David H Van Thiel; Ronald Herberman; Theresa L Whiteside
Natural killer activity of human liver-derived lymphocytes in various liver diseases.
Hepatology (Baltimore, Md.) 1991;14(3):495-503.
1991: David Tweardy; Penelope A Morel; Ronald Herberman; M Sakurai
Inhibition of growth of mouse leukemic cell lines in vitro and in vivo by a monoclonal antibody that recognizes an interleukin 3 receptor-associated protein.
Cancer research 1991;51(16):4355-9.
1991: Andrew A Amoscato; A M Brumfield; S B Sansoni; Ronald Herberman; William Chambers
Natural killer cell cytolytic granule-associated enzymes. I. Purification, characterization, and analysis of function of an enzyme with sulfatase activity.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(3):950-8.
1991: Per H Basse; Ronald Herberman; Ulf Nannmark; Bengt R Johansson; Marianne Hokland; K Wasserman; Ronald H Goldfarb
Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases.
The Journal of experimental medicine 1991;174(2):479-88.
1991: E M Letessier; D S Heo; T Okarma; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Cancer research 1991;51(15):3891-9.
1991: Per H Basse; Ulf Nannmark; Bengt R Johansson; Ronald Herberman; Ronald H Goldfarb
Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells.
Journal of the National Cancer Institute 1991;83(13):944-50.
1991: Hannah Rabinowich; P Sedlmayr; Ronald Herberman; Theresa L Whiteside
Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.
Cellular immunology 1991;135(2):454-70.
1991: L Pricop; C Galatiuc; M Manciulea; Albert B DeLeo; A Sulica; Ronald Herberman; Theresa L Whiteside
Expression of Fc mu receptors on human natural killer cells.
Clinical immunology and immunopathology 1991;59(3):355-67.
1991: A Sasaki; R J Melder; T L Whiteside; Ronald Herberman; Rakesh K Jain
Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation.
Journal of the National Cancer Institute 1991;83(6):433-7.
1991: M Sacchi; D Vitolo; P Sedlmayr; Hannah Rabinowich; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Induction of tumor regression in experimental model of human head and neck cancer by human A-LAK cells and IL-2.
International journal of cancer. Journal international du cancer 1991;47(5):784-91.
1991: Elieser Gorelik; M Begoviĉ; L Duty; Ronald Herberman
Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor.
Cancer research 1991;51(5):1521-8.
1991: Ronald Herberman
Sources of confounding in immunologic data.
Reviews of infectious diseases 1991;13 Suppl 1():S84-6.
1991: S M Levy; John D Fernstrom; Ronald Herberman; T Whiteside; J Lee; M Ward; M Massoudi
Persistently low natural killer cell activity and circulating levels of plasma beta endorphin: risk factors for infectious disease.
Life sciences 1991;48(2):107-16.
1991: R J Melder; E Walker; Ronald Herberman; Theresa L Whiteside
Adhesion characteristics of human interleukin 2-activated natural killer cells.
Cellular immunology 1991;132(1):177-92.
1991: S M Levy; Ronald Herberman; Marc Lippman; T D'Angelo; J Lee
Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer.
Behavioral medicine (Washington, D.C.) 1991;17(2):67-75.
1991: Y Shimizu; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
Cancer immunology, immunotherapy : CII 1991;32(5):280-8.
1991: S M Levy; Ronald Herberman; J Lee; Theresa L Whiteside; M Beadle; L Heiden; A Simons
Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity.
Natural immunity and cell growth regulation 1991;10(6):289-307.
1991: Mario Piccoli; Giorgio Santoni; Angela Santoni; Luigi Frati; Ronald Herberman; M A Chirigos
Inhibition of NK cell generation by Corynebacterium parvum.
Immunopharmacology and immunotoxicology 1991;13(4):513-29.
1990: Y Shimizu; S Iwatsuki; Ronald Herberman; T L Whiteside
Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
International journal of cancer. Journal international du cancer 1990;46(5):878-83.
1990: E M Letessier; M Sacchi; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
Cellular immunology 1990;130(2):446-58.
1990: Elieser Gorelik; G Jay; B Kwiatkowski; Ronald Herberman
Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(5):1621-32.
1990: K Hata; X R Zhang; S Iwatsuki; David H Van Thiel; Ronald Herberman; Theresa L Whiteside
Isolation, phenotyping, and functional analysis of lymphocytes from human liver.
Clinical immunology and immunopathology 1990;56(3):401-19.
1990: R J Melder; Raghavan Balachandran; Charles Rinaldo; Phalguni Gupta; Theresa L Whiteside; Ronald Herberman
Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells.
AIDS research and human retroviruses 1990;6(8):1011-5.
1990: R J Melder; E R Walker; Ronald Herberman; Theresa L Whiteside
Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.
Journal of leukocyte biology 1990;48(2):163-73.
1990: Marcel R M van den Brink; SS Boggs; Ronald Herberman; J C Hiserodt
The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures.
The Journal of experimental medicine 1990;172(1):303-13.
1990: D S Heo; J G Park; K Hata; R Day; Ronald Herberman; Theresa L Whiteside
Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
Cancer research 1990;50(12):3681-90.
1990: M Sacchi; Carl H Snyderman; D S Heo; Jonas T Johnson; F D'Amico; Ronald Herberman; Theresa L Whiteside
Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
Cancer research 1990;50(10):3113-8.
1990: J P McCoy; K Hanley-Yanez; A Brumfield; Ronald Herberman; William Chambers
Alterations in cell-surface carbohydrates of rat large granular lymphocytes associated with interleukin-2 activation.
Cellular immunology 1990;127(2):275-83.
1990: Carlo Riccardi; Graziella Migliorati; Lorenza Cannarile; F D'Adamio; L Frati; Ronald Herberman
In vivo effects of cytokines on development of natural killer cells and antitumor activity in lethally irradiated bone marrow transplanted recipients.
Journal of biological response modifiers 1990;9(1):15-23.
1990: S M Levy; Ronald Herberman; Theresa L Whiteside; K Sanzo; J Lee; J Kirkwood
Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients.
Psychosomatic medicine 1990;52(1):73-85.
1990: Z L Chang; Theresa L Whiteside; Ronald Herberman
Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity.
Cellular immunology 1990;125(1):183-96.
1990: Theresa L Whiteside; J Bryant; R Day; Ronald Herberman
Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.
Journal of clinical laboratory analysis 1990;4(2):102-14.
1990: Angela Santoni; Giorgio Santoni; Mario Piccoli; Ronald Herberman; Luigi Frati
Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity.
Immunopharmacology and immunotoxicology 1990;12(3):363-87.
1990: Theresa L Whiteside; Ronald Herberman
Serum and tissue banks for biological markers.
Immunology series 1990;53():55-68.
1990: Theresa L Whiteside; Ronald Herberman
The biology of human natural killer cells.
Annali dell'Istituto superiore di sanità 1990;26(3-4):335-48.
1990: S M Levy; Ronald Herberman; J Lee; Theresa L Whiteside; J Kirkwood; S McFeeley
Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.
Natural immunity and cell growth regulation 1990;9(5):313-24.
1989: M Manciulea; L Pricop; A Sulica; Ronald Herberman
Inhibition of human natural killer cell activity by polyclonal IgM.
Molecular immunology 1989;26(12):1087-93.
1989: Y L Wang; S Kaplan; Theresa L Whiteside; Ronald Herberman
In vitro effects of an acyltripeptide, FK565, on antitumor effector activities and on metabolic activities of human monocytes and granulocytes.
Immunopharmacology 1989;18(3):213-22.
1989: Y L Wang; L S Si; Anisa Kanbour; Ronald Herberman; Theresa L Whiteside
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
Cancer research 1989;49(21):5979-85.
1989: A Adler; V Albo; Julie Blatt; Theresa L Whiteside; Ronald Herberman
Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission.
Blood 1989;74(5):1690-7.
1989: Theresa L Whiteside; Ronald Herberman
The role of natural killer cells in human disease.
Clinical immunology and immunopathology 1989;53(1):1-23.
1989: D S Heo; Carl H Snyderman; Susanne M Gollin; S Pan; E Walker; R Deka; E Leon Barnes; Jonas T Johnson; Ronald Herberman; Theresa L Whiteside
Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Cancer research 1989;49(18):5167-75.
1989: R E Schwarz; S Iwatsuki; Ronald Herberman; Theresa L Whiteside
Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors.
Hepatology (Baltimore, Md.) 1989;10(2):221-7.
1989: A Sasaki; Rakesh K Jain; A A Maghazachi; R H Goldfarb; Ronald Herberman
Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution.
Cancer research 1989;49(14):3742-6.
1989: Y L Wang; Theresa L Whiteside; D Friberg; Ronald Herberman
In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells.
Immunopharmacology 1989;17(3):175-85.
1989: Z L Chang; Xiao-Li Huang; Charles Rinaldo; Ronald Herberman; Theresa L Whiteside
Up-regulation of natural killer activity of human immunodeficiency virus-infected patients by in vitro-differentiated macrophages.
Clinical immunology and immunopathology 1989;51(1):133-9.
1989: Donald V Cramer; J B Harnaha; Ronald Herberman
The use of 5-fluorouracil to enhance natural killer activity in rat bone marrow.
Transplantation proceedings 1989;21(2):3275-6.
1989: William Chambers; Nikola L Vujanovic; Albert B DeLeo; M W Olszowy; Ronald Herberman; J C Hiserodt
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
The Journal of experimental medicine 1989;169(4):1373-89.
1989: S M Levy; Ronald Herberman; J K Lee; Marc Lippman; T d'Angelo
Breast conservation versus mastectomy: distress sequelae as a function of choice.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(3):367-75.
1989: Y Gunji; Nikola L Vujanovic; J C Hiserodt; Ronald Herberman; Elieser Gorelik
Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(5):1748-54.
1989: M Sarneva; Nikola L Vujanovic; Marcel R M van den Brink; Ronald Herberman; J C Hiserodt
Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells.
Cellular immunology 1989;118(2):448-57.
1989: R J Melder; C S Rosenfeld; Ronald Herberman; Theresa L Whiteside
Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man.
Cancer immunology, immunotherapy : CII 1989;29(1):67-73.
1989: Ronald Herberman
Interleukin-2 therapy of human cancer: potential benefits versus toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):1-4.
1989: S M Levy; Ronald Herberman; A Simons; T Whiteside; J Lee; R McDonald; M Beadle
Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates.
Natural immunity and cell growth regulation 1989;8(3):173-86.
1989: J C Hiserodt; Ronald Herberman
Natural killer cells and tumor immunity.
The Year in immunology 1989;6():197-207.
1989: Mohamed A Virji; D W Mercer; Ronald Herberman
New immunologic markers for monitoring of cancer.
Annales chirurgiae et gynaecologiae 1989;78(1):13-26.
1989: Graziella Migliorati; Lorenza Cannarile; Ronald Herberman; Carlo Riccardi
Effect of various cytokines and growth factors on the interleukin-2-dependent in vitro differentiation of natural killer cells from bone marrow.
Natural immunity and cell growth regulation 1989;8(1):48-55.
1989: J C Hiserodt; Ronald Herberman
Natural killer cells and tumor immunity: 1987.
The Year in immunology 1989;4():201-7.
1989: S Takagi; K Chen; R Schwarz; S Iwatsuki; Ronald Herberman; T L Whiteside
Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2.
Cancer 1989;63(1):102-11.
1989: Roderich E Schwarz; S Iwatsuki; Ronald Herberman; T L Whiteside
Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumors.
Cancer immunology, immunotherapy : CII 1989;30(5):312-6.
1989: M Gherman; Ronald Herberman; A Sulica
Effect of interleukin-2 on the monomeric IgG-induced inhibition of human natural killer cell activity.
Natural immunity and cell growth regulation 1989;8(5):255-65.
1989: A Punturieri; F Velotti; Mario Piccoli; Ronald Herberman; Luigi Frati; Angela Santoni
Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL.
Clinical and experimental immunology 1989;75(1):155-60.
1989: Theresa L Whiteside; D S Heo; S Takagi; Ronald Herberman
Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes.
Immunology series 1989;48():139-57.
1989: A Sulica; M Gherman; M Manciulea; C Galatiuc; Ronald Herberman
Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types.
Natural immunity and cell growth regulation 1989;8(5):266-78.
1989: Ronald Herberman
Natural killer cells.
Progress in clinical and biological research 1989;288():161-7.
1988: A A Maghazachi; R H Goldfarb; Ronald Herberman
Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(11):4039-46.
1988: Theresa L Whiteside; Y L Wang; R G Selker; Ronald Herberman
In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
Cancer research 1988;48(21):6069-75.
1988: A A Maghazachi; Ronald Herberman; Nikola L Vujanovic; J C Hiserodt
In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells.
Cellular immunology 1988;115(1):179-94.
1988: H S Jaffe; Ronald Herberman
Rationale for recombinant human interferon-gamma adjuvant immunotherapy for cancer.
Journal of the National Cancer Institute 1988;80(9):616-8.
1988: Z L Chang; E Bonvini; L Varesio; H T Holden; Ronald Herberman
Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin.
Cellular immunology 1988;114(2):282-92.
1988: J C Hiserodt; William Chambers; Ronald Herberman
Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo.
Annales de l'Institut Pasteur. Immunology 1988;139(4):466-78.
1988: A C Bancu; M Gherman; A Sulica; T Goto; W Farrar; Ronald Herberman
Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity.
Cellular immunology 1988;114(2):246-56.
1988: R J Melder; Theresa L Whiteside; Nikola L Vujanovic; J C Hiserodt; Ronald Herberman
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.
Cancer research 1988;48(12):3461-9.
1988: D S Heo; T L Whiteside; A Kanbour; Ronald Herberman
Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(11):4042-9.
1988: M Pislarasu; A Oproiu; D Taranu; Ronald Herberman; A Sulica
Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
Cancer research 1988;48(9):2596-603.
1988: A A Maghazachi; Nikola L Vujanovic; Ronald Herberman; J C Hiserodt
Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2846-52.
1988: antonio procopio; Angela Gismondi; Rossella Paolini; Stefania Morrone; Roberto Testi; Mario Piccoli; Luigi Frati; Ronald Herberman; Angela Santoni
Proliferative effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophores on human large granular lymphocytes (LGL).
Cellular immunology 1988;113(1):70-81.
1988: Theresa L Whiteside; D S Heo; S Takagi; Ronald Herberman
Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes.
Transplantation proceedings 1988;20(2):347-50.
1988: Elieser Gorelik; Y Gunji; Ronald Herberman
H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(6):2096-102.
1988: A Adler; P A Chervenick; Theresa L Whiteside; E Lotzová; Ronald Herberman
Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission.
Blood 1988;71(3):709-16.
1988: Mohamed A Virji; D W Mercer; Ronald Herberman
Tumor markers in cancer diagnosis and prognosis.
CA: a cancer journal for clinicians 1988;38(2):104-26.
1988: Nikola L Vujanovic; Ronald Herberman; M W Olszowy; Donald V Cramer; R R Salup; C W Reynolds; J C Hiserodt
Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Cancer research 1988;48(4):884-90.
1988: Nikola L Vujanovic; Ronald Herberman; J C Hiserodt
Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
Cancer research 1988;48(4):878-83.
1988: Theresa L Whiteside; D S Heo; S Takagi; Jonas T Johnson; S Iwatsuki; Ronald Herberman
Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2.
Cancer immunology, immunotherapy : CII 1988;26(1):1-10.
1988: Nikola L Vujanovic; Ronald Herberman; A A Maghazachi; J C Hiserodt
Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.
The Journal of experimental medicine 1988;167(1):15-29.
1988: Graziella Migliorati; Lorenza Cannarile; Ronald Herberman; Carlo Riccardi
Role of interferons in natural killer cell generation from primitive bone marrow precursors.
International journal of immunopharmacology 1988;10(6):665-73.
1987: D S Heo; Theresa L Whiteside; Jonas T Johnson; K N Chen; E Leon Barnes; Ronald Herberman
Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
Cancer research 1987;47(23):6353-62.
1987: T Barlozzari; Ronald Herberman; C W Reynolds
Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(21):7691-5.
1987: M Gherman; M Manciulea; A C Bancu; A Sulica; D R Stanworth; Ronald Herberman
Regulation of human natural cytotoxicity by IgG--I. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity.
Molecular immunology 1987;24(7):743-50.
1987: S Yamada; F W Ruscetti; W R Overton; Ronald Herberman; M C Birchenall-Sparks; J R Ortaldo
Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
Journal of leukocyte biology 1987;41(6):505-17.
1987: G Migliorati; Lorenza Cannarile; Ronald Herberman; A Bartocci; E Richard Stanley; C Riccardi
Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(11):3618-25.
1987: Ronald Herberman
Lymphocyte-mediated cytotoxicity.
Pediatric annals 1987;16(6):485, 488-93.
1987: John R Ortaldo; Clive Woodhouse; A C Morgan; Ronald Herberman; D A Cheresh; R Reisfeld
Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(10):3566-72.
1987: I Screpanti; A Santoni; A Gulino; Ronald Herberman; L Frati
Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes.
Cellular immunology 1987;106(2):191-202.
1987: Ronald Herberman
Augmentation of NK cell activity by IL-2.
Progress in clinical and biological research 1987;244():267-74.
1987: Theresa L Whiteside; D S Heo; K Chen; A Adler; Jonas T Johnson; Ronald Herberman
Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
Progress in clinical and biological research 1987;244():213-22.
1987: J C Hiserodt; Nikola L Vujanovic; C W Reynolds; Ronald Herberman; Donald V Cramer
Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
Progress in clinical and biological research 1987;244():137-46.
1982: A Sulica; M Gherman; C Galatiuc; M Manciulea; Ronald Herberman
Inhibition of human natural killer cell activity by cytophilic immunoglobulin G.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(3):1031-6.